Free Cash Flow

Acorda Therapeutics Inc

Acorda Therapeutics Inc (ACOR)

$8.04
0.07 (+0.88%)

Free Cash Flow

Year
A/P
2013
Actual
2014
Actual
2015
Actual
2016
Actual
2017
Actual
2018
Actual
2019
Actual
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
Revenue 336.43401.48492.66519.60588.29471.43192.41186.53180.84175.32169.97164.78
Revenue (%)
Operating Cash Flow 39.2875.0238.4835.3596.50150.79-128.177.136.916.706.506.30
Operating Cash Flow (%)
Capital Expenditure -14.66-483.93-7.07-273.54-14.38-33.91-90.43-62.78-60.87-59.01-57.21-55.46
Capital Expenditure (%)
Free Cash Flow 24.62-408.9131.42-238.1982.12116.88-218.59-55.66-53.96-52.31-50.71-49.16

FCF Unlevered from cash flow statement